According to Novo Integrated Sciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.836928. At the end of 2023 the company had a P/S ratio of 1.46.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.46 | 99.19% |
2022 | 0.7312 | -80.23% |
2021 | 3.70 | -68.8% |
2020 | 11.9 | -8.72% |
2019 | 13.0 | -74.57% |
2018 | 51.1 | 262.57% |
2017 | 14.1 | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A | |
2012 | N/A | |
2011 | N/A | |
2010 | N/A | |
2009 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Select Medical Holdings SEM | 0.5480 | -34.52% | ๐บ๐ธ USA |
HealthSouth
EHC | 1.74 | 107.89% | ๐บ๐ธ USA |
Novo Integrated Sciences NVOS | 0.8369 | 0.00% | ๐บ๐ธ USA |